Literature DB >> 19261464

A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.

Paul van Gils1, Matthijs van den Berg, Henk van Kranen, Ardine G de Wit.   

Abstract

Colorectal cancer screening is an effective public health strategy for decreasing colorectal cancer mortality. Since many screening modalities exist, it needs to be determined what the most cost-effective strategy is. The aim of this review is to summarise the available cost-effectiveness evidence for colonoscopy versus CT-colonography screening, and to pay special attention to assumptions regarding test characteristics and adherence. A literature search resulted in twelve economic evaluations that could be included in the review. The incremental cost-effectiveness ratios of colonoscopy and CT-colonography versus no screening remained under 20,000 euro and 30,000 euro per life year gained, respectively. Although, both screening modalities were cost-effective according to most international thresholds, in most of the economic evaluations colonoscopy seemed more cost-effective than colonography screening. In many studies, model assumptions on major parameters (e.g. screening uptake) were more positive than real life data suggest. None of the models included indirect costs, which disproportionally favoured the relative cost-effectiveness of colonoscopy. For a good comparison of both screening methods, it is necessary that the assumptions used in economic evaluations are realistic, and include all costs.

Entities:  

Mesh:

Year:  2009        PMID: 19261464     DOI: 10.1016/j.ejca.2009.01.032

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

1.  Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model.

Authors:  Andrew Piscitello; Leila Saoud; A Mark Fendrick; Bijan J Borah; Kristen Hassmiller Lich; Michael Matney; A Burak Ozbay; Marcus Parton; Paul J Limburg
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

Review 2.  We screen newborns, don't we?: realizing the promise of public health genomics.

Authors:  James P Evans; Jonathan S Berg; Andrew F Olshan; Terry Magnuson; Barbara K Rimer
Journal:  Genet Med       Date:  2013-03-07       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.